Given the high prevalence of both diabetes and dementia in aging populations, this strategy may reduce long-term public health burdens, including healthcare costs, caregiver stress, and institutionalization needs. Szu-Yuan Wu, MD, MPH, PhD The researcher team also discovered that study participants taking GLP-1 agonists had a 25% lower risk of developing non-vascular dementias and a 12% lower chance of developing Alzheimers disease, compared to participants taking metformin
It is especially important for liver function.* What Is The Source
Once injected, Mecobalamin helps in the conversion of food into energy, supports nerve function, and aids in the production of red blood cells
GLP-1 medications carry risks including gastrointestinal symptoms, pancreatitis, and gallbladder disease, requiring specialist supervision